Increasing deal flow of projects ready for investment in the BioRegion: this is the main goal of the Investment Readiness Series, a new initiative from Biocat. Additionally, Biocat wants to add value to research projects through one-to-one mentoring, make it easier for projects scouting for partners by concentrating top-notch research, and establish a long-term relationship with TTOs, leveraging the impact of their work on an ecosystem level.
The Investment Readiness Series consists of several topic-specific calls per year, in which Biocat will bring together and mentor the top research projects in the BioRegion. Participants will have a chance to present their project to top relevant partners and investors and meet them in private meetings, including venture capitalists, companies and venture builders that are looking for outstanding health projects and participate in their development.
Partners will act as a pivotal assessment committee, depending on the topic launched in each call, with the opportunity to review the top projects from our ecosystem and select the ones they want to know more about.
The Investment Readiness Series is intended for research projects of both companies and research entities aiming to set up a company and who are willing to boost their project in line with industry and market requirements.
Biocat is looking for early stage health research projects in the valorization process that are established in the BioRegion of Catalonia and will be ready to be transferred or invested in within a year. More than one project per institution or principal investigator is allowed.
The Investment Readiness Series consists of the following steps:
Facilitating access to investors in the London, Cambridge and Oxford ecosystem (like AstraZeneca, Seroba Life Sciences, IP Group or Arix Bioscience) to companies from the BioRegion of Barcelona: this is the goal of 'The Investment Readiness Series in the City'.
Check this link for all the information about this edition.
The program is organized by Biocat and ACCIÓ, with collaboration from Newable, MedCity and Nucleus and support from the European Boost4Health program.
This edition is adressed to companies and advanced projects within the medtech, diagnostic or digital health sector and with relevant innovative technology.
Registration begins on November 28 and ends on January 3, 2019. Check this link to register and get all the information about this edition.
The Program is organized by Biocat with the collaboration of ACCIÓ and TecnoCampus Mataró.
Check in tthis link the program and all the information about this edition.
The event was organized by Biocat with the collaboration of Barcelona Tech city, Payment Innovation Hub, Reference Network in Biotechnology (XRB), ACCIÓ and Johnson & Johnson, and had the support of la Caixa Foundation.